Forensic · TNXP
Tonix Pharmaceuticals Holding Corp.
Top signals
Officer Departure Recent
C-suite officer departure (Item 5.02) in the last 6 months.
+4
Bear case preview · free
Tonix Pharmaceuticals triggered a low-risk alert based on recent officer departure, with a C-suite executive leaving within the last six months per Item 5.02 filing. While the overall red-flag score of 4/100 suggests minimal systemic distress, executive turnover at a clinical-stage biotech warrants scrutiny given the sector's dependence on leadership continuity and investor confidence. Watch upcoming quarterly filings and any additional management changes over the next 30-90 days, as a pattern of departures could signal deeper operational or strategic issues.
↑ That's free. The $9 report goes deeper: every filing cited by accession number, 36-month chronology, what to watch next.
What we checked
✓ Red flags · 36mo
1 8-K event (bankruptcy, delisting, restatement, auditor, officer)
✓ Cyber · 12mo
0 Item 1.05 disclosures + buried-cyber scan
✓ Dilution · 24mo
0 S-3 + 424B5 filings
✓ Buried events
Item 8.01 sections classified for hidden material disclosures
$9
· one-time · emailed in under a minute
The full bear case on TNXP
Plain-English brief. Every signal cited to the exact SEC filing. 36-month chronology. What changes next.
✓ No-signals refund: if the algorithm finds zero red flags on your ticker, reply "refund" and I send the $9 back same day. No questions.
Not ready to buy? Get a free preview by email instead
We'll email you the top 3 signals on TNXP + a discount code for the full report. No subscription, no spam.
Score another ticker
Not investment advice. Every signal grounded in a specific SEC filing. Companies may respond via info@filingfirehose.com.